Cytori Therapeutics to Provide Corporate Update at 2017 Biotech Showcase™
January 06 2017 - 7:30AM
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that the
company will present at the Biotech Showcase™ at 4:00 PM Pacific
Time (7:00 PM Eastern Time) on Tuesday, January 10, 2017. The
presentation will take place in Room 3 (Ballroom Level) at the
Hilton San Francisco Union Square.
Dr. Marc Hedrick, CEO and President of Cytori Therapeutics, will
provide an update on current corporate activities and recent
developments, including progress on its clinical pipeline.
A live audio webcast of the presentation will be available under
the investor relations section of Cytori’s website at
www.cytori.com. A replay of the presentation will be available for
90 days following the event. Please connect to Cytori’s website
several minutes prior to the start of the webcast to ensure
adequate time for any software download that may be necessary.
About Biotech Showcase
The Biotech Showcase 2017 Conference
(http://www.ebdgroup.com/bts/index.php) is one of the most
significant healthcare investor conferences of the year. It is
designed to provide private and public biotechnology and life
sciences companies the opportunity to present to, and meet with,
public and private investors, and pharmaceutical executives. This
is the 9th year for the Biotech Showcase. More than 2100 investors
and biopharmaceutical executives from around the world are expected
to attend.
About Cytori
Cytori Therapeutics is a late stage cell therapy company
developing autologous cell therapies from adipose tissue to treat a
variety of medical conditions. Data from preclinical studies and
clinical trials suggest that Cytori Cell Therapy™ acts principally
by improving blood flow, modulating the immune system, and
facilitating wound repair. As a result, Cytori Cell Therapy™ may
provide benefits across multiple disease states and can be made
available to the physician and patient at the point-of-care through
Cytori’s proprietary technologies and products. For more
information: visit www.cytori.com.
Cautionary Statement Regarding Forward-Looking
Statements
This press release includes forward-looking statements that
involve known and unknown risks and uncertainties. All statements,
other than historical facts are forward looking statements. Such
statements are subject to risks and uncertainties that could cause
our actual results and financial position to differ materially.
These risks and uncertainties are described under the "Risk
Factors" in Cytori's Securities and Exchange Commission Filings,
included in our annual and quarterly reports.
There may be events in the future that we are unable to predict,
or over which we have no control, and our business, financial
condition, results of operations and prospects may change in the
future. We assume no responsibility to update or revise any
forward-looking statements to reflect events, trends or
circumstances after the date they are made unless we have an
obligation under U.S. Federal securities laws to do so.
Cytori Therapeutics, Inc.
Tiago Girao, +1 (858) 458.0900
ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Apr 2023 to Apr 2024